Document Type
Conference Proceeding
Disciplines
Higher Education | Medicine and Health Sciences
Abstract
NA
DOI
https://doi.org/10.32873/unmc.dc.gmerj.7.1.069
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Recommended Citation
Elsayed, L. Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage Ⅰ-Ⅱ Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer. Graduate Medical Education Research Journal. 2025 Jun 30; 7(1).
https://digitalcommons.unmc.edu/gmerj/vol7/iss1/69
COinS
